How to judge the evidence
The most reliable evidence comes from randomised trials and their reviews, where a method is compared with placebo or another treatment. Small studies without a control group, patient testimonials and “before and after” images do not prove effectiveness. For many regenerative methods only small studies exist so far.
What is known by diagnosis
| Diagnosis | PRP / CGF | BMAC / MFAT | Basis of treatment in guidelines |
|---|---|---|---|
| Knee osteoarthritis | Moderate evidence: pain decreases for months in some patients; in the RESTORE trial PRP was no better than placebo | Little data | Exercise, weight loss; injections as an add-on |
| Hip osteoarthritis | Limited evidence | Little data | Exercise; joint replacement in advanced disease |
| Tennis elbow, plantar fasciitis | Conflicting evidence, some studies show benefit | Little data | Loading exercises, shockwave therapy |
| Herniated disc | Intradiscal injections — small studies, experimental | Experimental | Activity, exercise therapy, epidural injections, surgery when indicated |
| Avascular necrosis (early stage) | Little data | Limited evidence (BMAC with core decompression) | Core decompression early, joint replacement late |
| Rotator cuff tear | Limited evidence | Little data | Exercise therapy; repair for a complete tear |
What regenerative methods do not do
- They do not grow new cartilage: cartilage volume did not increase after injections in studies.
- They do not correct deformity or mechanical joint instability.
- They do not replace surgery for nerve compression with weakness or numbness.
- They do not guarantee a result: some patients see no effect.
How cell preparations are regulated in the EU
Minimally processed preparations from your own blood, bone marrow or fat (PRP, BMAC, MFAT) are used by doctors as part of medical practice. If cells are treated with enzymes or grown in a laboratory (for example SVF or cultured stem cells), they count as an advanced therapy medicinal product in the EU and need an authorisation. Offers of “stem cells” without such authorisation are a warning sign.
How to judge a clinic’s offer
- What studies exist for my diagnosis and stage?
- How many procedures are planned, and what if there is no effect?
- Which preparation is used and how is it obtained?
- Is it injected under ultrasound or X-ray guidance?
- What does the price include and which costs may be added?
We send your request to several clinics, so you can compare what each offers and how it justifies it. If you wish, send your images for a second opinion.
Scientific evidence
Guidelines and studies this page is based on:
- Bannuru RR et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019.
- Bennell KL et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial. JAMA, 2021.
- Belk JW et al. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Am J Sports Med, 2021.
- Pas HI et al. Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br J Sports Med, 2017.
- Peerbooms JC et al. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial. Am J Sports Med, 2010.
- Tuakli-Wosornu YA et al. Lumbar intradiskal platelet-rich plasma (PRP) injections: a prospective, double-blind, randomized controlled study. PM R, 2016.
Frequently asked questions about the evidence
Want to know what suits you? Send your images
Send your MRI or ultrasound and describe where and when it hurts. The coordinator replies within 24 hours; a clinic physician gives an opinion in 1–3 business days.
Send images
